Skip to main content

COVID-19 Vaccine Acceleration Research Grants

Supporting the research and development of next-generation COVID-19 vaccines in NSW

New vaccine vial

NSW Health invites applications for the NSW COVID-19 Vaccine Acceleration Research Grants Program.

Funding of up to $1 million per project for a period of up to 24 months is available from the Office for Health and Medical Research.

Applications for this grant closed at midday on 22 August 2022.

A peer review period of all applications will take place during August and September with funded applications to be announced during October 2022.

About the Program

The NSW COVID-19 Vaccine Acceleration Research Grants Program has been designed to:

  • Specifically support research projects at Technology Readiness Levels 3B-6 (see Appendix A of the Guidelines below) that can rapidly undertake preclinical or early phase clinical studies to develop next-generation COVID-19 vaccines
  • Support research projects that address an unmet need in current COVID-19 vaccines, including (but not limited to) improving:
    • vaccine safety profile
    • resistance to new and/or multiple variants of SARS-CoV-2
    • vaccine efficacy
    • responses in immunocompromised or other at-risk populations
    • the longevity of immunity
  • Reduce the time from evidence generation to implementation, through rapid planning, conduct and reporting of research that will make good progress towards commercialisation and translation into clinical practice and policy
  • Fund collaboration, leadership and capacity-building in the NSW vaccine research environment
  • Bridge a funding gap which may halt the progress of next-generation COVID-19 vaccine research and development in NSW, and
  • Support research that will add value to existing or planned initiatives, within the current Australian and international research landscape.

Apply now

  • COVID-19 Vaccine Acceleration Research Program Application Form

    DOCX - 98 KB

 

 

 

 

 

Updated 3 months ago